{
    "nctId": "NCT02406794",
    "briefTitle": "Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women Given Breast Cancer Survivors",
    "officialTitle": "Effect of Kinesiotaping for the Treatment of Hormone-induced Myalgia in Women: Randomised Controlled Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 156,
    "primaryOutcomeMeasure": "Medical questionnaire",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* To be of legal age\n* Having suffered from primary breast cancer with histological confirmation (I-IIIA)\n* Completion of primary carcinoma treatment (surgery, chemotherapy, radiotherapy)\n* To be receiving hormone therapy as an adjunct to the process by aromatase inhibitors (exemestane, anastrozole, letrozole)\n* To present a functional status according to WHO from 0 (asymptomatic, complete and ambulatory activity) or 1 (symptomatic but completely ambulatory, strenuous physical activity restricted but able to perform sedentary gentle activities)\n* To understand correctly Spanish\n* To show their approval by signing the informed consent\n* Having had musculoskeletal disorders attributable to IA.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}